Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Avi Kapoor

THE TRUTH ABOUT: Jazz pharmaceuticals sigma lithium zymeworks and other big stocks moving higher on monday | History Defined

Display,Of,Stock,Market,Quotes

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday.

Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) rose sharply during Monday's session after the company announced top-line results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera in combination with chemotherapy, with or without the PD-1 inhibitor Tevimbra, as first-line treatment for HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma, including cancers of the stomach, gastroesophageal junction and esophagus.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.